The 3 Kinds of Skin Cancer

When it comes to the different kinds of skin cancer, there are basically three. Basal cell carcinoma, squamous cell carcinoma and melanoma. Some are treatable if caught early.

Buy me a coffee, please!

Clinical outcome of breast cancer occurring after treatment for Hodgkin’s lymphoma: case-control analysis

Background:
To evaluate diagnosis, management and outcome of breast cancer (BC) occurring after irradiation for Hodgkin’s lymphoma (HL).
Methods:
39 cases of BC in 28 HL survivors were retrospectively reviewed. 21 patients were included in a case-control analysis.
Results:
The median age at diagnosis of HL and BC was 25.3 and 45.3 years, respectively. The median interval to develop BC was 16.1 years. Eleven women (39.2%) had bilateral disease. Mode of detection of the index breast cancers was by mammographic screening in 17 patients (60.7%), palpable lump in 8 patients (28.6%), clinical examination in two patients (7.1%), and unknown in one patient (3.6%). Case-control analysis showed that histological features and prognosis of BC after HL were similar to those of primary BC, however, for BC after HL, mastectomy was the predominant surgery (P = 0.001) and adjuvant radiotherapy and anthracycline-based chemotherapy were less frequently used as compared to primary BC (P < 0.001 and 0.003, respectively).
Conclusions:
The previous history of HL does not appear to be a poor prognostic factor for BC occurring thereafter.

Buy me a coffee, please!

Beautiful Skin - Causes and Signs of Skin Cancer

In order to understand how skin cancer develops, one should first have an idea on the parts of the skin and how they function. It is important that we are aware of how skin cancer develops and how it can be prevented to avoid its fatal consequences.

Buy me a coffee, please!

Massage Therapist Saves a Life!

Massage Therapist Saves a Life! We all know massage offers great benefits to clients, everything from physical to emotional wellbeing, but I was as surprised as the doctor, when a massage turned out to be a lifesaver. While giving my athletic firefighter husband a relaxing massage, I found a melanoma on the bottom arch of his right foot, the last place you would expect to find it.

Buy me a coffee, please!

Lung Cancer Alliance Hails Signing Of Tobacco Control Legislation Into Law; Urges Action On Lung Cancer

WASHINGTON — Landmark legislation giving the Food and Drug Administration (FDA) the power to regulate tobacco products was signed into law at a White House ceremony today. The federal government can now regulate the amount of nicotine in tobacco products, ban flavorful additives, require every chemical ingredient to be detailed on the label and prohibit deceptive marketing and ads that target the young. Lung Cancer Alliance President Laurie Fenton-Ambrose said, “This puts us on a whole new track in helping current smokers to quit and in preventing new generations of young people from ever becoming addicted in the first place.” “And, hopefully,” said Fenton, “this will also mark a new track for lung cancer research…

Buy me a coffee, please!

Women Underrepresented In Most Cancer Research

Women continue to be under-enrolled in cancer clinical trials, according to a new review, published in the July 15, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society. The study’s results suggest that greater efforts are needed to ensure that oncologists know the true effects of treatments and medical procedures in female patients. In 1993, the National Institutes of Health called for clinical trials to include adequate representation of women. To define better the representation of women as subjects in the full range of high-impact, clinical cancer research published currently, Reshma Jagsi, MD, DPhil of the University of Michigan in Ann Arbor and colleagues reviewed cancer clinical research appearing in eight…

Buy me a coffee, please!

Defeating Nicotine’s Double Role In Lung Cancer

A lung cancer treatment that inhibits nicotine receptors was shown to double survival time in mice, according to Italian researchers. The results of the early phase animal model study were reported in the June 15 issue of the American Journal of Respiratory and Critical Care Medicine. Changes in genes encoding nicotine receptors are strongly associated not only with the tendency to smoke, but with susceptibility to lung cancer. Nicotine exposure also heightens the expression of the nicotine receptors, which leads to increased cell proliferation and inhibition of apoptosis, further setting the stage for cancer. Patrizia Russo, Ph.D. and Laura Paleari, Ph.D. of the Lung Cancer Unit of the National Cancer Research Institute in Genoa,…

Buy me a coffee, please!

Don’t Ignore Skin Cancer Warning Signs

As we move toward beach season, we’ll all be spending more time outdoors and raising our chances of joining the ranks of the 1 million people the American cancer Society tells us are diagnosed with skin cancer each year, which is why it’s vital not to ignore skin cancer warning signs. Experts firmly believe many of these cancers are sun related, which means there are things you can do, even in the summer or at the beach, to protect yourself and those you love from this most common of cancers.

Buy me a coffee, please!

Melanoma Skin Cancer - If You Thought Moles Were the Only Symptom, Then You Had Better Read This

Malignant Melanoma can be cured in 95% of cases if detected early (this is what I have been told). That last part is the real kicker. EARLY!

Buy me a coffee, please!

The Lowdown on Skin Cancer

Skin is our largest organ and one that is not immune to developing cancerous cells. Skin cancer develops when damaged cells start growing and dividing uncontrollably in the skin. This form of cancer is the most prevalent with more than one million cases in the United States diagnosed each year. Here we will cover some of the commonly asked questions about skin cancer.

Buy me a coffee, please!

The Lowdown on Skin Cancer

Skin is our largest organ and one that is not immune to developing cancerous cells. Skin cancer develops when damaged cells start growing and dividing uncontrollably in the skin. This form of cancer is the most prevalent with more than one million cases in the United States diagnosed each year. Here we will cover some of the commonly asked questions about skin cancer.

Buy me a coffee, please!

Lung Cancer Alliance Issues Statement On FDA Tobacco Regulation Bill

WASHINGTON — Today, the U.S. House of Representatives overwhelmingly endorsed the U.S. Senate version of the FDA tobacco regulation bill with a 307-97 vote — an emphatic exclamation point for the successful conclusion of a decade long battle. The final stop is the President’s desk and a signing ceremony is expected to be held next week. Lung Cancer Alliance President Laurie Fenton Ambrose called its passage an historic moment [...] Continue Reading…

Buy me a coffee, please!

Brain Irradiation In Lung Cancer

A national Radiation Therapy Oncology Group (RTOG) study led by a Medical College of Wisconsin Cancer Center physician at Froedtert Hospital in Milwaukee has found that a course of radiation therapy to the brain after treatment for locally advanced non-small cell lung cancer reduced the risk of metastases to the brain within the first year after treatment. The study was presented at the American Society of Clinical Oncology annual [...] Continue Reading…

Buy me a coffee, please!

Non Melanomatous Skin Cancer in Ireland

Many Irish people incorrectly feel that they are only at risk of skin cancer when holidaying abroad. However, the annual National cancer Registry report details how there were nearly 8,000 cases of non-melanoma skin cancer in 1997 alone. This means that skin cancer is now the most common form of cancer in Ireland and presently accounts for about a third of all Irish cancers. It is accepted that excessive [...] Continue Reading…

Buy me a coffee, please!

The Increasing Incidence of Cutaneous Malignant Melanoma (CMM) In Ireland

Cutaneous malignant melanoma (CMM), is considered the most serious type of skin cancer because of its rapid ability to spread to other parts of the body, including the eye. It starts when melanocytes become abnormal and invade and destroy the normal cells around them. Melanoma can begin either in an existing mole or as a new growth on the skin. The number of people in the world who develop [...] Continue Reading…

Buy me a coffee, please!

Monte Carlo dose verification of prostate patients treated with simultaneous integrated boost intensity modulated radiation therapy

Background:
To evaluate the dosimetric differences between Superposition/Convolution (SC) and Monte Carlo (MC) calculated dose distributions for simultaneous integrated boost (SIB) prostate cancer intensity modulated radiotherapy (IMRT) compared to experimental (film) measurements and the implications for clinical treatments.
Methods:
Twenty-two prostate patients treated with an in-house SIB-IMRT protocol were selected. SC-based plans used for treatment were re-evaluated with EGS4-based MC calculations for treatment verification. Accuracy was evaluated with-respect-to film-based dosimetry. Comparisons [...] Continue Reading…

Buy me a coffee, please!

Skin Cancer Prevention - 5 Crucial, Yet Critical Tips

As summer approaches, we are all reminded how quickly the beautiful, warm sun causes premature aging and also skin cancer. But is there a balance between enjoying the sun and also have piece of mind knowing you are reducing your risk of skin cancer? Absolutely.

Buy me a coffee, please!

Test Developed For Measuring Lung Cancer Risk

New Zealand researchers said Tuesday they have developed the world’s first test to measure the risk for individual smokers and ex-smokers of developing lung cancer. The test combines results of DNA analysis with other risk factors such as age, diseases such as bronchitis and emphysema and family lung cancer history, said University of Auckland associate professor Robert Young. “All smokers face an increased risk of developing lung cancer, among [...] Continue Reading…

Buy me a coffee, please!

National Early Lung Cancer Detection Study Finds Nine Cancers In Six Months

VANCOUVER — In six months, nine Canadians have been diagnosed with lung cancer while participating in a Terry Fox Research Institute study for the early detection of lung cancer. The study is funded in partnership with the Canadian Partnership Against Cancer. The diagnosed participants live in Halifax, Quebec City, Hamilton and Vancouver and were enrolled in the program currently under way in these cities. The early detection study is [...] Continue Reading…

Buy me a coffee, please!

Heaviest Smokers Face Greatest Risk Of Death After Lung Cancer Diagnosis

MORGANTOWN, W.V. — It’s common knowledge that smoking raises risks of lung cancer. And yet researchers haven’t known whether continued smoking by lung cancer patients would increase the risk of the cancer’s spread. Researchers at West Virginia University - studying the relationship between death rates from lung cancer and how much a person smoked - have found that smoking intensity in fact predicts how the disease will progress. Patients [...] Continue Reading…

Buy me a coffee, please!

Phase III Study Data With Vandetanib In Patients With Advanced

ORLANDO, FL — Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Data from the Phase III ZODIAC(1) study in advanced non-small cell lung cancer patients, with the investigational drug vandetanib, were presented today at the American Society of Clinical Oncology (ASCO) meeting in Orlando. Results show that the study met its primary endpoint, demonstrating that the addition of vandetanib to docetaxel resulted in a statistically significant [...] Continue Reading…

Buy me a coffee, please!

Maintenance Treatment With Avastin And Tarceva Aids Lung Cancer

BASEL — Roche announced today that the Phase III ATLAS study showed patients with advanced non-small cell lung cancer (NSCLC) who received Avastin(R) (bevacizumab) and Tarceva(R) (erlotinib) as combined first-line maintenance treatment had a 39 percent improvement in the time they lived without the disease advancing (progression-free survival or PFS, the primary endpoint of the study), compared with those who received Avastin alone[1]. The ATLAS study was stopped early [...] Continue Reading…

Buy me a coffee, please!

Maintenance Treatment With Avastin And Tarceva Aids Lung Cancer

BASEL — Roche announced today that the Phase III ATLAS study showed patients with advanced non-small cell lung cancer (NSCLC) who received Avastin(R) (bevacizumab) and Tarceva(R) (erlotinib) as combined first-line maintenance treatment had a 39 percent improvement in the time they lived without the disease advancing (progression-free survival or PFS, the primary endpoint of the study), compared with those who received Avastin alone[1]. The ATLAS study was stopped early [...] Continue Reading…

Buy me a coffee, please!

Constitutive gene expression profile segregates toxicity in locally advanced breast cancer patients treated with high-dose hyperfractionated radical radiotherapy

breast cancer patients show a wide variation in normal tissue reactions after radiotherapy. The individual sensitivity to x-rays limits the efficiency of the therapy. Prediction of individual sensitivity to radiotherapy could help to select the radiation protocol and to improve treatment results. The aim of this study was to assess the relationship between gene expression profiles of ex vivo un-irradiated and irradiated lymphocytes and the development of toxicity due [...] Continue Reading…

Buy me a coffee, please!

Study Suggests Hormone Pills May Make Lung Cancer More Deadly

ORLANDO, Fla. — There’s more troubling news about hormone therapy for menopause symptoms: Lung cancer seems more likely to prove fatal in women who are taking estrogen-progestin pills, a study suggests. Hormone users who developed lung cancer were more than twice as likely to die from the disease as women who weren’t taking hormones, according to results reported Saturday. The new findings mean that smokers should stop taking hormones, [...] Continue Reading…

Buy me a coffee, please!

Pfizer Data Identify Certain Lung Cancer Patients Who May Benefit From Treatment With Figitumumab

ORLANDO, Fla. — Pfizer announced today results from studies evaluating the company’s investigational anti-insulin growth factor- type 1 receptor (IGF-1R) antibody, figitumumab (CP-751,871), in patients with non-small cell lung cancer (NSCLC). A total of three abstracts were presented at the 45th Annual American Society of Clinical Oncology (ASCO) annual meeting in Orlando. “As we try to find the right drug to use in the right setting for each patient, [...] Continue Reading…

Buy me a coffee, please!

Phase III Study Data With Vandetanib In Patients With Advanced Non-small Cell Lung Cancer

ORLANDO, Fla. — Data from the Phase III ZODIAC study in advanced non-small cell lung cancer patients, with the investigational drug vandetanib, were presented today at the American Society of Clinical Oncology (ASCO) meeting in Orlando. Results show that the study met its primary endpoint, demonstrating that the addition of vandetanib to docetaxel resulted in a statistically significant improvement in progression-free survival (PFS), the length of time a patient [...] Continue Reading…

Buy me a coffee, please!

Lung Cancer Alliance Calls American Cancer Society’s Claim Of Progress Selective

WASHINGTON — Lung Cancer Alliance (LCA) said that the American Cancer Society’s claim of “progress in cancer fight” earlier this week was based on “selective culling of statistics and ignores the dismal truth that we have made very little progress on the most lethal cancers, including lung cancer, which causes one in every two cancer deaths, or in metastatic cancer of any kind.” LCA President & CEO Laurie Fenton [...] Continue Reading…

Buy me a coffee, please!

Radiotherapy quality assurance review in a multi-center randomized trial of limited-disease small cell lung cancer: the Japan Clinical Oncology Group (JCOG) trial 0202

Background:
The purpose of this study was to analyze the radiotherapy (RT) quality assurance (QA) assessment in Japan Clinical Oncology Group (JCOG) 0202, which was the first trial that required on-going RT QA review in the JCOG.
Methods:
JCOG 0202 was a multi-center phase III trial comparing two types of consolidation chemotherapy after concurrent chemoradiotherapy for limited-disease small cell lung cancer. RT requirements included a total dose of 45 Gy / 30 [...] Continue Reading…

Buy me a coffee, please!

Michael Jackson’s Skin Cancer

The King of Pop is not without problems. With the many controversies of him suffering from skin cancer and the faking of his skin turning from black to white, Michael Jackson is suffering from the potentially fatal disease of skin cancer. Jackson has been enduring many treatments to get rid of the cancer spreading on his skin. With scrapings of his chest and nose already completed, the King of [...] Continue Reading…

Buy me a coffee, please!

WordPress Themes